Myeongmun Pharmaceutical has ranked among the top searched stocks on four days within the past month.


As of 1:30 PM on the 24th, Myeongmun Pharmaceutical is trading at 7,590 KRW, down 4.77% from the previous day. This represents a 20.02% decline compared to December 22. Myeongmun Pharmaceutical is known as a comprehensive pharmaceutical company focusing on prescription drugs.

Today, foreigners have net purchased 204,558 shares of Myeongmun Pharmaceutical, while institutions have net sold 33,000 shares, according to provisional data. Over the past five days, individual investors have net purchased 55,139 shares, and foreigners and institutions have net purchased 203 shares and 30,065 shares, respectively.


On December 22, Myeongmun Pharmaceutical was a market topic due to the news of sales of 'Camostat' for COVID-19 suppression, which led to an upward trend.




[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing